News
ATRC
32.90
-13.11%
-4.97
AtriCure slides 15% after JPMorgan downgrades over Edwards competition
Seeking Alpha · 3h ago
Piper Sandler Sticks to Their Buy Rating for Atricure (ATRC)
TipRanks · 9h ago
AtriCure: Solid Growth Drivers but Rising Competitive Threat from Edwards Justifies Neutral Stance
TipRanks · 10h ago
AtriCure downgraded to Neutral from Overweight at JPMorgan
TipRanks · 11h ago
ATRICURE INC <ATRC.O>: JP MORGAN CUTS TO NEUTRAL FROM OVERWEIGHT; CUTS TARGET PRICE TO $36 FROM $48
Reuters · 17h ago
Weekly Report: what happened at ATRC last week (0202-0206)?
Weekly Report · 2d ago
First Week of March 20th Options Trading For AtriCure (ATRC)
NASDAQ · 02/04 15:58
Atricure (ATRC) Receives a New Rating from BTIG
TipRanks · 02/04 07:36
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX)
TipRanks · 02/03 12:50
Weekly Report: what happened at ATRC last week (0126-0130)?
Weekly Report · 02/02 09:54
AtriCure Inc. to Announce Fourth Quarter and Full Year Financial Results
Reuters · 01/27 17:08
Press Release: AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
Dow Jones · 01/27 13:05
Weekly Report: what happened at ATRC last week (0119-0123)?
Weekly Report · 01/26 09:54
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices
NASDAQ · 01/23 09:14
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years
NASDAQ · 01/20 16:04
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
NASDAQ · 01/20 16:00
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
NASDAQ · 01/19 17:40
Weekly Report: what happened at ATRC last week (0112-0116)?
Weekly Report · 01/19 09:58
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
NASDAQ · 01/16 17:46
DexCom Stock Declines Following Strong Preliminary Q4 Results
NASDAQ · 01/16 17:42
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.